Content
Cannabidiol is a substance extracted from the cannabis plant, Cannabis sativa, which acts on the central nervous system, being useful in the treatment of psychiatric or neurodegenerative diseases, such as multiple sclerosis, schizophrenia, Parkinson's disease, epilepsy or anxiety, for example.
Currently, in Brazil, there is only one drug with cannabidiol authorized for sale, with the name Mevatyl, which has another substance added, tetrahydrocannabinol, being indicated for the treatment of muscle spasms related to multiple sclerosis. Although for the moment only one drug with this substance is commercialized, the tendency is that other cannabis-based drugs are approved in Brazil, as long as their use is supervised by the doctor.
What is cannabidiol remedy for
In Brazil, there is only one cannabidiol medication authorized by Anvisa, with the name Mevatyl, which is indicated for the treatment of muscle spasms related to multiple sclerosis.
However, there are other products with cannabidiol, which are marketed in other countries, indicated for the treatment of epilepsy, Parkinson's or Alzheimer's disease, as analgesics in terminal cancer patients, for example, which can be imported, for specific cases and with proper authorization. .
There is still insufficient scientific evidence to prove that cannabinoids are completely safe and effective in the treatment of epilepsy, so there is only an indication for use in restricted cases, when other drugs indicated for this disease are not sufficiently effective.
In addition, cannabidiol has also revealed other benefits and pharmacological properties, such as analgesic and immunosuppressive action, action in the treatment of stroke, diabetes, nausea and cancer and effects on anxiety, sleep and movement disorders, which makes it a substance with great therapeutic potential. Learn more about the possible benefits of cannabidiol oil.
Watch the following video and see the therapeutic benefits of cannabidiol:
Where to buy
The only medication with cannabidiol authorized by Anvisa, has the name Mevatyl, and is indicated for the treatment of muscle spasms related to multiple sclerosis. This remedy is available in spray and can be purchased at pharmacies.
However, there are other products with cannabidiol, with other therapeutic purposes, whose marketing has been authorized in Brazil since March 2020, as long as it is obtained through a medical prescription and declaration of responsibility signed by the doctor and patient.
Possible side effects
The reported side effects do not only concern cannabidiol, but also tetrahydrocannabinol, as the drug Mevatyl has both substances in its composition. Tetrahydrocannabinol, also known as THC, is a psychoactive substance and is therefore more likely to cause side effects.
Some of the most common side effects that may occur during treatment with Mevatyl are dizziness, changes in appetite, depression, disorientation, dissociation, euphoric mood, amnesia, balance and attention disorders, poor coordination of speech muscles, changes in taste, lack of energy, impaired memory, drowsiness, blurred vision, dizziness, constipation, diarrhea, burning, ulceration, pain and dryness of the mouth, nausea and vomiting.